Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF has issued a Tender notice for the procurement of a Factorpath Chip-Seq Analysis in the USA. This Tender notice was published on 27 Aug 2022 and is scheduled to close on 30 Aug 2022, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 70893319, while the tender notice number is VS6413760 and Registering on the platform.
Procurement Summary
Country: USA
Summary: Factorpath Chip-Seq Analysis
Deadline: 30 Aug 2022
Posting Date: 27 Aug 2022
Other Information
Notice Type: Tender
TOT Ref.No.: 70893319
Document Ref. No.: VS6413760
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Description
The Chromatin and Gene Expression Group at the National Institute of Environmental Health Sciences is conducting research into the contributions of genetic and epigenetic diversity in the generation of induced pluripotent stem cells (IPSCs) from patient-derived dermal fibroblasts (DFs). The process of generating IPSCs from DFs is referred to as “reprogramming.” Reprogramming is a critical part of the expanding fields of precision and patient-specific medicine. Using our established cohort of DFs, we have identified key factors that contribute to the efficiency of the reprogramming process and result in disparity between individuals. However, the underlying genetic and epigenetic differences responsible for this disparity between individuals remains unclear. We require chromatin immunoprecipitation with sequencing (ChIP-seq) services to characterize the epigenetic profiles of our cohort of DFs. Our goal is to utilize these ChIP-seq services to determine how ancestry-, sex-, and age-related epigenetic differences contribute to differences in reprogramming efficiency.
The applicable North American industry Classification System (NAICS) Code for this procurement is 621511 “Medical Laboratories.” Its associated Business Size Standard is $36.5M.
Line item 1. 25001-FactorPath ChIP-Seq. (No Bioinformatics) (Qty.70 each)
Line item 2. 25011- HistonePath ChIP-Seq (No Bioinformatics) (Qty 93 each)
Line item 3. 25046- Input-Seq.-(Qty 2 each)
Period of performance: September 28, 2022-September 27, 2023Delivery: 10-12 Weeks, ARO
NIEHS will solicit and negotiate directly with Active Motif, and no solicitation will be issued. This notice of intent is not a request for competitive proposals or quotations; however, all responsible sources may submit a capability statement which shall be considered by the agency. Offerors must have an active registration in the System for Award Management (SAM.GOV) www.sam.gov. A determination by the Government n...
Documents
VS6413760-NOTICE-OF-INTENT-ACIVE-MOTIF-FACTORPATH-CHIP-SEQ.pdf
Procurement Documents for USA
Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA
Want To Bid in This Tender?
Get Local Agent Support in USA and 60 More Countries.
View Tenders By
Sign in with Google